^
BIOMARKER:
TLR8 overexpression
i
Other names: TLR8, Toll Like Receptor 8, CD288, CD288 Antigen
Entrez ID:
TLR8 overexpression
|
Melanoma
|
TLR8 overexpression
|
Melanoma
|
PD1 inhibitor Resistant: C3 – Early Trials
|
PD1 inhibitor Resistant: C3 – Early Trials
|
TLR8 overexpression
|
SCCHN
|
TLR8 overexpression
|
SCCHN
|
cetuximab + VTX 2337 Sensitive: D – Preclinical
|
cetuximab + VTX 2337 Sensitive: D – Preclinical
|
